Skip to content

    CorMedix (CRMD) stock price & financials

    View CRMD earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance41.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $11.46M
    $39.08M
    $39.74M
    $104.28M
    +810.2%
    $128.62M
    $127.43M
    +226.1%
    $101.93M
    +156.5%
    Strengthening
    Operating Profit
    -$3.29M
    $12.94M
    $20.13M
    $19.54M
    $51.35M
    $59.13M
    +357.1%
    $63.66M
    +216.3%
    $42.91M
    +119.6%
    Strengthening
    Net Profit
    -$2.78M
    $13.46M
    $20.64M
    $19.83M
    $108.56M
    $14.02M
    +4.1%
    $38.60M
    +87.0%
    $25.99M
    +31.1%
    Strengthening
    EPS
    $-0.05
    $0.32
    $0.29
    $1.42
    $0.48
    +50.0%
    $0.33
    +13.8%
    Strengthening
    Other Income
    $510.5K
    $527.8K
    $519.0K
    $806.0K
    $1.23M
    +141.0%
    -$2.68M
    -607.8%
    -$8.01M
    -1643.9%
    -$4.18M
    -618.2%
    Weakening
    Interest
    $10.0K
    $9.6K
    $10.0K
    $6.7K
    $948.2K
    +9375.8%
    $1.82M
    +18824.0%
    Strengthening
    Depreciation
    Profit before Tax
    -$2.78M
    $13.46M
    $20.64M
    $20.35M
    $52.58M
    $56.45M
    +319.2%
    $55.65M
    +169.5%
    $38.73M
    +90.3%
    Strengthening
    MarginsOPM
    -28.7%
    51.5%
    49.2%
    49.2%
    46.0%
    50.0%
    -3.0%
    42.1%
    -14.4%
    Weakening
    Tax
    0.0%
    2.6%
    -106.5%
    75.2%
    30.6%
    32.9%
    +1180.2%
    Strengthening
    ReturnsROIC
    2.5%
    -12.0%
    -18.4%
    -17.7%
    -97.0%
    -4009.6%
    -12.5%
    -4.1%
    -34.5%
    -87.0%
    -23.2%
    -31.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$17.62M$16.35M$41.91M$53.32M$43.15M$43.64M$40.65M$144.84M$256.69M
    Short-Term Investments$10.36M
    Total Current Assets$18.67M$29.35M$48.18M$66.47M$59.55M$79.45M$114.58M$367.05M$480.55M
    Net PP&E$160.9K$126.8K$1.13M$2.37M$2.38M$2.51M$2.32M$8.98M$7.85M
    Goodwill$30.00M$30.00M
    Intangibles$1.84M$379.07M$358.47M
    Total Assets$18.83M$29.48M$49.31M$68.95M$62.04M$82.06M$118.85M$826.14M$904.05M
    LiabilitiesTotal Current Liabilities$7.77M$5.83M$4.16M$5.35M$6.31M$11.40M$33.84M$174.27M$187.40M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$2.7K$923.7K$802.4K$667.6K$517.0K$349.0K$2.25M
    Total Liabilities$13.89M$5.83M$5.09M$6.15M$6.98M$11.92M$34.19M$420.83M$443.22M
    EquityCommon Stock & APIC$21.8K$25.7K$33.6K$38.1K$42.8K$54.9K$64.0K$79.0K$78.0K
    Retained Earnings-$178.99M-$195.42M-$217.45M-$245.66M-$275.36M-$321.70M-$339.63M-$176.57M-$111.99M
    Total Equity$4.93M$23.65M$44.22M$62.80M$55.06M$70.14M$84.66M$405.31M$460.83M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$23.70M-$15.05M-$21.97M-$21.16M-$24.36M-$38.41M-$50.62M$175.05M$253.94M
    Cash from Investing$1.56M-$12.02M$7.43M-$9.13M-$3.71M-$17.06M$21.23M-$308.43M-$285.62M
    Cash from Financing$29.40M$25.80M$40.10M$41.76M$17.90M$55.92M$26.32M$238.45M$129.95M
    SummaryCapital Expenditure-$48.9K-$36.6K-$112.6K-$1.43M-$219.4K-$327.3K-$116.0K-$2.26M-$3.52M
    Free Cash Flow-$23.75M-$15.09M-$22.08M-$22.58M-$24.58M-$38.74M-$50.73M$172.79M$250.42M
    FCF Margin-5525.7%-5326.7%-9229.7%-11826.2%-37573.5%-116.7%55.4%54.2%

    Ratios